2020-11-05,Orgenesis Third Quarter 2020 Revenue Increases 40% Reflecting Continued Progress of POCare Platform
2020-11-03,Orgenesis Announces Virtual 2020 Annual Meeting of Stockholders
2020-10-26,Did Orgenesis' (NASDAQ:ORGS) Share Price Deserve to Gain 44%?
2020-10-19,Orgenesis Completes Acquisition of Koligo Therapeutics and Announces Additional Acquisition of Icellator® Technology from Tissue Genesis in Related Transaction
2020-09-29,"Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies"
2020-09-09,"Orgenesis CEO to Participate in Webinar Panel on New Approaches to COVID-19 on Thursday, September 10th"
2020-08-20,"Orgenesis Selects Therapeutics, Inc. as CRO to Support Development and Planned Phase 2 Clinical Study of Ranpirnase for the Treatment of External Genital Warts"
2020-08-07,Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform
2020-08-06,Health Check: How Prudently Does Orgenesis (NASDAQ:ORGS) Use Debt?
2020-07-14,5 Health Care Stocks Trading With Low Price-Earnings Ratios
2020-07-14,Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies Using Orgenesis Proprietary POCare Technologies for the Generation and Expansion of T-Cells
2020-06-29,Orgenesis Added to Russell 3000® Index
2020-06-22,Orgenesis and Leidos Collaborate on Potential Treatment for COVID-19
2020-06-10,"Orgenesis Announces Anti-Viral BioShield Program Designed to Potentially Increase Preparedness, Rapidly Address Virus Spread and Protect Against Future Outbreaks such as COVID-19"
2020-06-01,Orgenesis to Collaborate with The Edith Wolfson Medical Center to Conduct Clinical Study Using Orgenesis Proprietary POCare Technologies for the Generation and Expansion of Tumor Infiltrating Lymphocytes
2020-05-22,"Orgenesis Announces Collaboration with Hospital Infantil Universitario Niño Jesús, Madrid, to Establish Point of Care Center"
2020-05-15,Orgenesis Announces Stock Repurchase Plan of Up to $10 Million
2020-05-13,Orgenesis Announces Cell-Based Vaccine Platform Targeting COVID-19 and other Existing and Emerging Viral Diseases
2020-05-11,Orgenesis First Quarter 2020 Revenue Increases 348% to $1.9 Million Reflecting Success of CGT Biotech Platform
2020-04-29,Orgenesis CEO Vered Caplan Recognized Among World's Top 20 Inspirational Leaders in Advanced Medicine in The Medicine Maker 'Power List 2020'
2020-04-27,"Orgenesis Completes Acquisition of Tamir Biotechnology, Inc. Assets Including Broad Spectrum Antiviral Platform"
2020-04-15,Framebridge now producing face shields; Metro recommends riders wear masks
2020-04-13,"Orgenesis Announces Agreement to Acquire Assets of Tamir Biotechnology, Inc. Including Broad Spectrum Antiviral Platform"
2020-04-08,Orgenesis Announces Joint Venture Agreement with RevaTis to Produce Muscle-Derived Mesenchymal Stem Cells (mdMSC) as a Source of Exosomes and Other Cellular Products for the Development of Related Therapies
2020-03-31,"Orgenesis and ExcellaBio Announce Breakthrough Manufacturing Process for Bioxomes, Proprietary Synthetic Exosomes/Extracellular Vesicles (EV)"
2020-03-30,Orgenesis CEO Vered Caplan Provides Letter to Shareholders
2020-03-10,Orgenesis Provides Fiscal 2019 Year-End Results and Business Update; Outlines New Vertically Integrated Business Model and POCare Strategy Following Sale of Masthercell
2020-03-09,What Kind Of Share Price Volatility Should You Expect For Orgenesis Inc. (NASDAQ:ORGS)?
2020-02-19,Orgenesis Announces Collaboration with The John Hopkins University for the Development and Processing of Cell and Gene Based Clinical Therapeutics
2020-02-11,Orgenesis Completes Sale of Masthercell Subsidiary; Receives Approximately $127 Million in Net Proceeds
2020-02-04,"The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares"
2020-02-03,"Orgenesis Announces Agreement for the Sale of Masthercell Global, its Contract Development and Manufacturing Organization (CDMO) Subsidiary"
2020-02-03,"Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform"
2020-01-21,Orgenesis Inc. Announces $9.2 Million Private Placement
2020-01-13,Orgenesis Appoints Industry Veteran Mario Philips to its Board of Directors
2020-01-10,"Orgenesis Announces Addition of University of California, Davis, to its Point of Care Network; UC Davis Health to Utilize Orgenesis Point of Care Platform for the Development, Commercialization and Supply of Cell and Gene Therapy Products"
2019-12-23,Orgenesis Announces Receipt of the $6.6 Million Second Milestone Payment into Masthercell Global Subsidiary
2019-12-11,Hedge Funds Have Never Been More Bullish On Superior Industries International Inc. (SUP)
2019-12-06,Orgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers within HYGEIA Groups Hospital Network in Greece
2019-11-26,Orgenesis Ranked 5th Fastest Growing Technology Company in Maryland and 208th in North America on Deloitte's 2019 Technology Fast 500
2019-11-22,"Orgenesis Inc. Reminds Stockholders to Vote in Favor of All Proposals at the Annual Meeting of Stockholders to be Held on November 26, 2019"
2019-11-13,Orgenesis CEO Appears as a Guest on i24 News Network
2019-11-08,Orgenesis Third Quarter 2019 Revenue Increases 46% to a Record $9.1 Million
2019-10-31,Orgenesis Appoints Bala S. Manian to its Scientific Advisory Board
2019-10-28,Orgenesis to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
2019-10-16,Orgenesis Announces Co-Development Agreement with Accellix
2019-09-10,Is Orgenesis Inc. (NASDAQ:ORGS) Excessively Paying Its CEO?
2019-09-09,Orgenesis to Present at the 2019 Janney Healthcare Conference
2019-08-14,Orgenesis Reorganizes Its Israel and Korea Subsidiaries to Support Continued Growth
2019-08-12,Orgenesis Second Quarter 2019 Revenue Increases 95% to a Record $7.8 Million
2019-06-17,U.S. stocks set to rise cautiously as Federal Reserve gathering comes into focus
2019-06-17,Orgenesis shares soar 19% premarket after FDA grants orphan designation to insulin tech
2019-06-17,Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy
2019-05-09,Orgenesis First Quarter 2019 Revenue Increases 177% to a Record $7.3 Million
2019-04-30,Orgenesis Announces Planned Study to Confirm Suitability of Liver Cells as a Source for Personalized Cell Replacement Therapy for Insulin-Dependent Diabetic Patients
2019-04-24,Those Who Purchased Orgenesis (NASDAQ:ORGS) Shares A Year Ago Have A 53% Loss To Show For It
2019-04-23,MicroCap Review Magazine Spring 2019 Issue Now Available
2019-04-22,"Orgenesis Announces Collaboration Agreement with Columbia University to Develop Cellular Vaccination Product Platform for Pancreatic, Hepatic and Cholangiocarcinoma Cancers"
2019-04-11,Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio
2019-04-08,Will Orgenesis Inc. (ORGS) Report Negative Q1 Earnings? What You Should Know
2019-04-04,Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use
2019-04-03,Orgenesis Announces Publication of an Independent Study The Role of The Vasculature Niche on Insulin Producing Cells Generated by Transdifferentiation of Adult Human Liver Cells in the Stem Cell Research and Therapy Journal
2019-03-28,Orgenesis Signs Master Service and Joint Venture Agreement with TheraCell Advanced Biotechnology for the Development of Cell and Gene Therapies
2019-03-27,"Orgenesis Inc. Provides 2018 Corporate Highlights, Clinical Development and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.com"
2019-03-25,Orgenesis Subsidiary Masthercell Global Announces Plans to Establish New Facility for Cell and Gene Therapy Commercial Manufacturing
2019-03-07,Does Orgenesis Inc.s (NASDAQ:ORGS) CEO Pay Compare Well With Peers?
2019-02-14,Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018
2019-02-11,Orgenesis CEO to Participate in Panel at the 2019 BIO CEO & Investor Conference
2019-02-06,Orgenesis CSO Sara Ferber to Present to the International Research Training Group Hosted by Technische Universität Dresden and the King's College London
2019-02-05,"Orgenesis Announces the Opening of New Offices and Laboratories at Accessia Pharma in Liège, Belgium to Support its Point of Care Cellular Therapy Platform"
2019-01-25,Orgenesis Announces U.S. Expansion of Masthercell Global Subsidiary
2019-01-22,Penny Stocks to Buy Using Technical Analysis for January 2019
2019-01-22,Orgenesis Subsidiary Atvio Biotech to Present at Phacilitate Leaders World 2019 Conference
2019-01-03,Orgenesis CEO Selected to Participate in Cell and Gene Therapy Workshop at Biotech Showcase 2019 in California
2018-12-31,"Analysis: Positioning to Benefit within PPL, Inseego, Scientific Games, Orgenesis, CUI Global, and TRACON Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results"
2018-12-18,Orgenesis Announces Collaboration with MangoGen Pharma for Advanced Gene Delivery Platform
2018-12-13,Orgenesis CEO Vered Caplan to Appear on Fox Business Networks Mornings with Maria
2018-12-12,Orgenesis CEO Vered Caplan to Present at William Blairs Biotech Focus Day Series: Cell and Gene Therapy Manufacturing
2018-12-12,Orgenesis Announces Collaboration with Ben-Gurion University to Research and Develop Dissolvable Carriers for Cell Culturing
2018-12-04,"Orgenesis Announces that Dr. Ohad Karnieli, CEO of Atvio Biotech, a Wholly-Owned Subsidiary of Masthercell Global, will Present at the Cell Therapy Manufacturing & Gene Therapy Congress"
2018-11-30,Orgenesis Subsidiary Masthercell Global Expands Production and Doubles its Capacity
2018-11-21,"Orgenesis Announces Collaboration with the New York Blood Center for Tissue Collection, Processing and Biobanking U.S. Cell Therapy Development Program"
2018-11-19,"Detailed Research: Economic Perspectives on Miller Industries, P & F Industries, Schmitt Industries, Orgenesis, AMERI, and TrovaGene  What Drives Growth in Today's Competitive Landscape"
2018-11-15,How Does Orgenesis Inc (NASDAQ:ORGS) Affect Your Portfolio Volatility?
2018-11-02,How Orgenesis is breaking barriers in biotech
2018-11-02,Orgenesis CEO Vered Caplan to Appear Live Today on Midday Movers on Yahoo Finance
2018-10-23,Orgenesis to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
2018-10-22,Orgenesis Announces Collaboration with Hemogenyx to Develop Blood Stem Cell Replacement Product
2018-10-19,Orgenesis Announces Collaboration with Immugenyx to Develop and Commercialize Advanced Hematopoietic Chimeras
2018-10-18,Orgenesis CEO to Participate in Panel Presentation at The Cellular Living Drug Revolution Summit in New York City
2018-10-18,Orgenesis Subsidiary Masthercell Global Announces Manufacturing Services Agreement with Iovance Biotherapeutics in Europe
2018-10-18,Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe
2018-10-15,Orgenesis Reports 143% Increase in Revenue and 316% Increase in Gross Profit for the Third Quarter of Fiscal 2018
2018-10-11,Orgenesis to Provide Keynote Address and Poster Presentation at the 2018 International Conference on Diabetes and Endocrinology
2018-10-04,Orgenesis Announces License Agreement with HekaBio in Japan
2018-10-01,Kangstem Biotech Selects Orgenesis Subsidiary Masthercell for GMP Manufacturing of Furestem-AD© in Europe
2018-09-28,Orgenesis Announces Poster Presentation at the 54th Annual Meeting of the European Association of the Study of Diabetes
2018-08-23,Orgenesis Announces Collaboration with Ben-Gurion University to Develop and Commercialize a Novel Scaffold Technology for Cell Transplantation
2018-08-15,"Orgenesis Announces that Dr. Ohad Karnieli, CEO of Atvio Biotech, a Wholly-Owned Subsidiary of Masthercell Global, will Present at the 2018 Bioprocessing Summit"
2018-07-30,"Orgenesis Announces Collaboration between Secant Group and Atvio Biotech, a Wholly Owned Subsidiary of Masthercell Global, to Develop and Commercialize Scaffold Technologies for Advanced Cell Therapies"
